{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:37:44Z","timestamp":1782362264724,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pleuroparenchymal fibroelastosis (PPFE) is a rare fibrosing lung disease with a predilection for the upper lobe and its progression causes hypoventilation, resulting in hypercapnia. Even though the association between sleep-related hypoventilation (SRH) and chronic obstructive pulmonary disease was well documented, its impact in patients with PPFE was not evaluated. The aim of this study is to clarify the impact of SRH on prognosis in PPFE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective review of the medical records of 52 patients with PPFE who underwent transcutaneous carbon dioxide monitoring during sleep was done.<\/jats:p>\n                <jats:p>Patients were stratified into SRH (n\u2009=\u200928) and non-SRH (n\u2009=\u200924) groups based on American Academy of Sleep Medicine criteria. The impact of SRH on the prognosis of PPFE, as well as the clinical factors and comorbidities of PPFE associated with SRH, were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forced expiratory volume in the first second (FEV<jats:sub>1<\/jats:sub>), forced vital capacity (FVC), total lung capacity (TLC), and carbon monoxide diffusing capacity (DLco) in the SRH group were significantly lower than the non-SRH group (P\u2009&lt;\u2009.01). Chronic pulmonary aspergillosis (CPA) was found at a higher rate in the SRH group (P\u2009=\u2009.02). The median survival time for SRH patients was 330\u00a0days, whereas roughly 80% of non-SRH patients were alive during the 3-year observation period (P\u2009&lt;\u2009.01). Body mass index was a significant prognostic factor in PPFE patients with SRH (HR .78; 95% CI; .64\u2013.94; P\u2009&lt;\u2009.01). Home oxygen therapy (HOT) during the day and noninvasive positive pressure ventilation (NPPV) at night while sleeping tended to improve prognosis in the SRH group, as indicated by HR of .25 (P\u2009=\u2009.07).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SRH may be a poor prognostic factor for PPFE. Additionally, SRH may modify susceptibility to Aspergillosis in patients with PPFE. HOT plus NPPV may improve the disease outcomes in patients with SRH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02224-1","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T10:02:56Z","timestamp":1667210576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of sleep-related hypoventilation in patients with pleuroparenchymal fibroelastosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuki","family":"Yabuuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizu","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Oh-ishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hayashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2224_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13665-017-0160-5","volume":"6","author":"M Bonifazi","year":"2017","unstructured":"Bonifazi M, Montero MA, Renzoni EA. Idiopathic pleuroparenchymal fibroelastosis. Curr Pulmonol Rep. 2017;6:9\u201315.","journal-title":"Curr Pulmonol Rep"},{"key":"2224_CR2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1513\/AnnalsATS.201902-181CME","volume":"16","author":"F Chua","year":"2019","unstructured":"Chua F, Desai SR, Nicholson AG, Devaraj A, Renzoni E, Rice A, et al. Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics. Ann Am Thorac Soc. 2019;16:1351\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"2224_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12931-018-0860-6","volume":"19","author":"K Tanizawa","year":"2018","unstructured":"Tanizawa K, Handa T, Kubo T, Chen-Yoshikawa TF, Aoyama A, Motoyama H, et al. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study. Respir Res. 2018;19:162.","journal-title":"Respir Res"},{"key":"2224_CR4","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.","edition":"3"},{"key":"2224_CR5","first-page":"1273","volume":"7","author":"S B\u00f6ing","year":"2015","unstructured":"B\u00f6ing S, Randerath WJ. Chronic hypoventilation syndromes and sleep-related hypoventilation. J Thorac Dis. 2015;7:1273\u201385.","journal-title":"J Thorac Dis"},{"key":"2224_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0064-2019","volume":"28","author":"WT McNicholas","year":"2019","unstructured":"McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev. 2019;28: 190064.","journal-title":"Eur Respir Rev"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5664\/jcsm.4540","volume":"11","author":"R Budhiraja","year":"2015","unstructured":"Budhiraja R, Siddiqi TA, Quan SF. Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med. 2015;11:259\u201370.","journal-title":"J Clin Sleep Med"},{"key":"2224_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2147\/COPD.S153200","volume":"13","author":"T Kitajima","year":"2018","unstructured":"Kitajima T, Marumo S, Shima H, Shirata M, Kawashima S, Inoue D, et al. Clinical impact of episodic nocturnal hypercapnia and its treatment with noninvasive positive pressure ventilation in patients with stable advanced COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:843\u201353.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2224_CR9","doi-asserted-by":"publisher","unstructured":"Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2224_CR10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00004","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson JC, Vittinghoff E, Ryu HJ, Tomassetti S, Lee SJ, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012. https:\/\/doi.org\/10.7326\/0003-4819-156-10-201205150-00004.","journal-title":"Ann Intern Med"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4187\/respcare.07408","volume":"65","author":"GA Schmidt","year":"2020","unstructured":"Schmidt GA. Monitoring gas exchange. Respir Care. 2020;65:729\u201338.","journal-title":"Respir Care"},{"key":"2224_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.rmed.2010.10.007","volume":"105","author":"JH Storre","year":"2011","unstructured":"Storre JH, Magnet FS, Dreher M, Windisch W. Transcutaneous monitoring as a replacement for arterial PCO2 monitoring during nocturnal non-invasive ventilation. Respir Med. 2011;105:143\u201350.","journal-title":"Respir Med"},{"key":"2224_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1183\/09059180.00006713","volume":"23","author":"T Harada","year":"2014","unstructured":"Harada T, Yoshida Y, Kitasato Y, Tsuruta N, Wakamatsu K, Hirota T, et al. The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis. Eur Respir Rev. 2014;23:263\u20136.","journal-title":"Eur Respir Rev"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/jcm10040846","volume":"10","author":"T Oda","year":"2021","unstructured":"Oda T, Sekine A, Tabata E, Iwasawa T, Takemura T, Ogura T. Comparison of clinical characteristics and outcomes between idiopathic and secondary pleuroparenchymal fibroelastosis. J Clin Med. 2021;10:846.","journal-title":"J Clin Med"},{"key":"2224_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12931-021-01810-z","volume":"22","author":"Y Kinoshita","year":"2021","unstructured":"Kinoshita Y, Ikeda T, Miyamura T, Ueda Y, Yoshida Y, Kushima H, et al. A proposed prognostic prediction score for pleuroparenchymal fibroelastosis. Respir Res. 2021;22:215.","journal-title":"Respir Res"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6043053","volume":"2018","author":"M Shioya","year":"2018","unstructured":"Shioya M, Otsuka M, Yamada G, Umeda Y, Ikeda K, Nishikiori H, et al. Poorer prognosis of idiopathic pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis in advanced stage. Can Respir J. 2018;2018:1\u20137.","journal-title":"Can Respir J"},{"key":"2224_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.resinv.2021.09.010","volume":"60","author":"T Ikeda","year":"2022","unstructured":"Ikeda T, Kinoshita Y, Miyamura T, Ueda Y, Yoshida Y, Kushima H, et al. Platythorax progresses with lung involvement in pleuroparenchymal fibroelastosis. Respir Investig. 2022;60:293\u20139.","journal-title":"Respir Investig"},{"key":"2224_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1183\/09031936.00165111","volume":"40","author":"TL Reddy","year":"2012","unstructured":"Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377\u201385.","journal-title":"Eur Respir J"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.resinv.2020.05.009","volume":"58","author":"M Namba","year":"2020","unstructured":"Namba M, Masuda T, Takao S, Terada H, Yamaguchi K, Sakamoto S, et al. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis. Respir Investig. 2020;58:465\u201372.","journal-title":"Respir Investig"},{"key":"2224_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.11.003","volume":"133","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, et al. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study. Respir Med. 2017;133:1\u20135.","journal-title":"Respir Med"},{"key":"2224_CR21","unstructured":"Global Strategy for Diagnosis, management, and prevention of COPD\u20142016 [Internet]. The global initiative for chronic obstructive lung disease (GOLD). https:\/\/goldcopd.org\/global-strategy-diagnosis-management-prevention-copd-2016\/. Accessed 26 Aug 2022."},{"key":"2224_CR22","unstructured":"Global Initiative for Asthma [Internet]. Glob. Initiat. Asthma\u2014GINA. https:\/\/ginasthma.org\/. Accessed 26 Aug 2022."},{"key":"2224_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","volume":"47","author":"DW Denning","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47:45\u201368.","journal-title":"Eur Respir J"},{"key":"2224_CR24","doi-asserted-by":"publisher","unstructured":"American Thoracic Society\/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. https:\/\/doi.org\/10.1164\/ajrccm.165.2.ats01","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"2224_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.resinv.2015.02.003","volume":"53","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Waseda Y, Takato H, Matsunuma R, Johkoh T, Egashira R, et al. Pleuroparenchymal fibroelastosis: Distinct pulmonary physiological features in nine patients. Respir Investig. 2015;53:149\u201355.","journal-title":"Respir Investig"},{"key":"2224_CR26","doi-asserted-by":"publisher","first-page":"147997311986794","DOI":"10.1177\/1479973119867945","volume":"16","author":"H Ishii","year":"2019","unstructured":"Ishii H, Kinoshita Y, Kushima H, Nagata N, Watanabe K. The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis. Chron Respir Dis. 2019;16:147997311986794.","journal-title":"Chron Respir Dis"},{"key":"2224_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/1573398X0904140129125307","volume":"9","author":"K Watanabe","year":"2013","unstructured":"Watanabe K. Pleuroparenchymal fibroelastosis: its clinical characteristics. Curr Respir Med Rev. 2013;9:229\u201337.","journal-title":"Curr Respir Med Rev"},{"key":"2224_CR28","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.2.7633704","author":"DJM Jones","year":"2012","unstructured":"Jones DJM, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med. 2012. https:\/\/doi.org\/10.1164\/ajrccm.152.2.7633704.","journal-title":"Am J Respir Crit Care Med"},{"key":"2224_CR29","first-page":"870","volume":"46","author":"K Fukushima","year":"2008","unstructured":"Fukushima K, Marut K, Kiyofuji C. Sugimoto M [Evaluation of the incidence of pneumothorax and background of patients with pneumothorax during noninvasive positive pressure ventilation]. Nihon Kokyuki Gakkai Zasshi. 2008;46:870\u20134.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2224_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nmd.2004.03.002","volume":"14","author":"A Vianello","year":"2004","unstructured":"Vianello A, Arcaro G, Gallan F, Ori C, Bevilacqua M. Pneumothorax associated with long-term non-invasive positive pressure ventilation in Duchenne muscular dystrophy. Neuromuscul Disord. 2004;14:353\u20135.","journal-title":"Neuromuscul Disord"},{"key":"2224_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.rmed.2010.11.010","volume":"105","author":"A-M Kelly","year":"2011","unstructured":"Kelly A-M, Klim S. Agreement between arterial and transcutaneous PCO2 in patients undergoing non-invasive ventilation. Respir Med. 2011;105:226\u20139.","journal-title":"Respir Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02224-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T22:03:32Z","timestamp":1667253812000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02224-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02224-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted with approval from Institutional Ethics Committee in Ibaraki Higashi national Hospital (No. 2019-027). The opt-out method was used for patient consent instead of obtaining informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}